What is he best known for?
The fields of study he is best known for:
His primary areas of investigation include Internal medicine, Endocrinology, Receptor, Growth hormone secretagogue and Peptide sequence.
His study in the field of Agonist, Ghrelin, Peptide hormone and G protein also crosses realms of Somatosensory system.
His research in Agonist intersects with topics in Melanocortin 4 receptor and Brainstem.
His Receptor research is multidisciplinary, relying on both In situ hybridization and Cell biology.
Andrew D. Howard combines subjects such as Growth hormone secretagogue receptor, Pituitary gland and Somatostatin with his study of Growth hormone secretagogue.
Andrew D. Howard usually deals with Peptide sequence and limits it to topics linked to Peptide and Cysteine protease, Active site and Affinity labeling.
His most cited work include:
- A novel heterodimeric cysteine protease is required for interleukin-1 beta processing in monocytes. (2141 citations)
- A Receptor in Pituitary and Hypothalamus That Functions in Growth Hormone Release (1821 citations)
- Distribution of mRNA encoding the growth hormone secretagogue receptor in brain and peripheral tissues. (976 citations)
What are the main themes of his work throughout his whole career to date?
The scientist’s investigation covers issues in Receptor, Internal medicine, Endocrinology, Biochemistry and Agonist.
His biological study spans a wide range of topics, including In situ hybridization and Cell biology.
All of his Internal medicine and Insulin, Growth hormone secretagogue, Hypothalamus, Growth hormone secretagogue receptor and Somatostatin investigations are sub-components of the entire Internal medicine study.
Andrew D. Howard applies his multidisciplinary studies on Endocrinology and Thyrotropin-releasing hormone receptor in his research.
His Agonist study integrates concerns from other disciplines, such as Bombesin Receptor Subtype-3, Melanocortin, Secretagogue and In vivo.
The concepts of his Peptide study are interwoven with issues in Peptide sequence and Stereochemistry.
He most often published in these fields:
- Receptor (47.58%)
- Internal medicine (44.35%)
- Endocrinology (44.35%)
What were the highlights of his more recent work (between 2015-2020)?
- Internal medicine (44.35%)
- Endocrinology (44.35%)
- Free fatty acid receptor 1 (8.87%)
In recent papers he was focusing on the following fields of study:
The scientist’s investigation covers issues in Internal medicine, Endocrinology, Free fatty acid receptor 1, Insulin and Agonist.
His work carried out in the field of Internal medicine brings together such families of science as Incretin and Glucagon-like peptide-1.
His research on Endocrinology often connects related topics like Metabolic stability.
His Free fatty acid receptor 1 study is concerned with the field of Receptor as a whole.
His research in Receptor is mostly focused on Allosteric regulation.
Andrew D. Howard has researched Agonist in several fields, including Enteroendocrine cell and Mechanism of action.
Between 2015 and 2020, his most popular works were:
- Targeting a ceramide double bond improves insulin resistance and hepatic steatosis. (93 citations)
- Neurotensin Is Coexpressed, Coreleased, and Acts Together With GLP-1 and PYY in Enteroendocrine Control of Metabolism. (91 citations)
- GPR119, a Major Enteroendocrine Sensor of Dietary Triglyceride Metabolites Coacting in Synergy With FFA1 (GPR40) (49 citations)
In his most recent research, the most cited papers focused on:
Endocrinology, Internal medicine, Agonist, Glucose homeostasis and Enteroendocrine cell are his primary areas of study.
His Endocrinology study combines topics from a wide range of disciplines, such as Free fatty acid receptor 1 and Peptide YY.
His Peptide YY study combines topics in areas such as Neurotensin and Glucagon-like peptide-1, Proglucagon.
His research related to Lipolysis, Pancreatic islets and Secretagogue might be considered part of Internal medicine.
His Pancreatic islets research includes elements of Glycogen and Hormone, Glucagon.
His Secretagogue research is classified as research in Receptor.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
